LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Acute phase characteristics and long-term complications of pulmonary embolism in COVID-19 compared to non-COVID-19 cohort: a large single-centre study.

    Franco-Moreno, A / Brown-Lavalle, D / Campos-Arenas, M / Rodríguez-Ramírez, N / Muñoz-Roldán, C / Rubio-Aguilera, A I / Muñoz-Rivas, N / de Girón, J Bascuñana-Morejón / Fernández-Vidal, E / Palma-Huerta, E / Estévez-Alonso, S / Rodríguez-Gómez, B / Manzano-Valera, S / Pedrero-Tomé, R / Casado-Suela, M / Bibiano-Guillén, C / Mir-Montero, M / Torres-Macho, J / Bustamante-Fermosel, A

    BMC pulmonary medicine

    2023  Volume 23, Issue 1, Page(s) 25

    Abstract: Background: To compare the severity of pulmonary embolism (PE) and the long-term complications between patients with and without COVID-19, and to investigate whether the tools for risk stratification of death are valid in this population.: Methods: ... ...

    Abstract Background: To compare the severity of pulmonary embolism (PE) and the long-term complications between patients with and without COVID-19, and to investigate whether the tools for risk stratification of death are valid in this population.
    Methods: We retrospectively included hospitalized patients with PE from 1 January 2016 to 31 December 2022. Comparisons for acute episode characteristics, risk stratification of the PE, outcomes, and long-term complications were made between COVID and non-COVID patients.
    Results: We analyzed 116 (27.5%) COVID patients and 305 (72.4%) non-COVID patients. In patients with COVID-19, the traditional risk factors for PE were absent, and the incidence of deep vein thrombosis was lower. COVID patients showed significantly higher lymphocyte count, lactate dehydrogenase, lactic acid, and D-dimer levels. COVID patients had PE of smaller size (12.3% vs. 25.5% main pulmonary artery, 29.8% vs. 37.1% lobar, 44.7% vs. 29.5% segmental and 13.2% vs. 7.9% subsegmental, respectively; p < 0.001), less right ventricular dysfunction (7.7% vs. 17.7%; p = 0.007) and higher sPESI score (1.66 vs. 1.11; p < 0.001). The need for mechanical ventilation was significantly higher in COVID patients (8.6% vs. 1.3%; p < 0.001); However, the in-hospital death was less (5.2% vs. 10.8%; p = 0.074). The incidence of long-term complications was lower in COVID cohort (p < 0.001). PE severity assessed by high sPESI and intermediate and high-risk categories were independently associated with in-hospital mortality in COVID patients.
    Conclusion: The risk of in-hospital mortality and the incidence of long-term complications were lower in COVID-19. The usual tools for risk stratification of PE are valid in COVID patients.
    MeSH term(s) Humans ; Hospital Mortality ; COVID-19/complications ; Retrospective Studies ; Pulmonary Embolism/complications ; Pulmonary Artery ; Risk Assessment
    Language English
    Publishing date 2023-01-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2059871-3
    ISSN 1471-2466 ; 1471-2466
    ISSN (online) 1471-2466
    ISSN 1471-2466
    DOI 10.1186/s12890-023-02323-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection.

    Franco-Moreno, Anabel / Brown-Lavalle, David / Rodríguez-Ramírez, Nicolás / Muñoz-Roldán, Candela / Rubio-Aguilera, Ana Ignes / Campos-Arenas, Maria / Muñoz-Rivas, Nuria / Moya-Mateo, Eva / Ruiz-Giardín, José Manuel / Pardo-Guimerá, Virginia / Ulla-Anes, Mariano / Pedrero-Tomé, Roberto / Torres-Macho, Juan / Bustamante-Fermosel, Ana

    Journal of clinical and translational research

    2023  Volume 9, Issue 2, Page(s) 59–68

    Abstract: Background and aim: We aimed to develop a clinical prediction model for pulmonary thrombosis (PT) diagnosis in hospitalized COVID-19 patients.: Methods: Non-intensive care unit hospitalized COVID-19 patients who underwent a computed tomography ... ...

    Abstract Background and aim: We aimed to develop a clinical prediction model for pulmonary thrombosis (PT) diagnosis in hospitalized COVID-19 patients.
    Methods: Non-intensive care unit hospitalized COVID-19 patients who underwent a computed tomography pulmonary angiogram (CTPA) for suspected PT were included in the study. Demographic, clinical, analytical, and radiological variables as potential factors associated with the presence of PT were selected. Multivariable Cox regression analysis to develop a score for estimating the pre-test probability of PT was performed. The score was internally validated by bootstrap analysis.
    Results: Among the 271 patients who underwent a CTPA, 132 patients (48.7%) had PT. Heart rate >100 bpm (OR = 4.63 [95% CI: 2.30-9.34];
    Conclusions: CHEDDAR score can be used to estimate the pre-test probability of PT in hospitalized COVID-19 patients outside the intensive care unit.
    Relevance for patients: Developing a new clinical prediction model for PT diagnosis in COVID-19 may help in the triage of patients, and limit unnecessary exposure to radiation and the risk of nephrotoxicity due to iodinated contrast.
    Language English
    Publishing date 2023-02-06
    Publishing country Singapore
    Document type Journal Article
    ZDB-ID 3019815-X
    ISSN 2424-810X ; 2382-6533
    ISSN (online) 2424-810X
    ISSN 2382-6533
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top